medicalnewstoday.com
85%
690
Diabetes drug may decrease COVID-19 death risk in women
The results of the recent investigation into metformin use, obesity, diabetes risk, and COVID-19 mortality appear in The Lancet Healthy Longevity.In the week ending November 28, 2020, the cumulative COVID-19 hospitalization rate in the United States reached a new peak.The reported mortality rate due to pneumonia, influenza, and COVID-19 was 12.8%, though the receipt of additional data is likely to increase this figure.People with certain medical conditions, including obesity and type 2 diabetes, have an increased risk of severe COVID-19, and may require hospitalization, intensive care, or mechanical ventilation.